Cargando…

Tumor Treating Fields in the Management of Patients with Malignant Gliomas

Malignant gliomas remain a challenging cancer to treat due to limitations in both therapeutic and efficacious options. Tumor treating fields (TTFields) have emerged as a novel, locoregional, antineoplastic treatment modality with favorable efficacy and safety being demonstrated in the most aggressiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghiaseddin, Ashley P., Shin, David, Melnick, Kaitlyn, Tran, David D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Neuro-oncology (GJ Lesser, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391234/ https://www.ncbi.nlm.nih.gov/pubmed/32734509 http://dx.doi.org/10.1007/s11864-020-00773-5

Ejemplares similares

An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
por: Wong, Eric T, et al.
Publicado: (2015)

The Role of Autophagy in Childhood Central Nervous System Tumors
por: Wang, Yafeng, et al.
Publicado: (2022)

Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)
por: Rodriguez-Almaraz, J. Eduardo, et al.
Publicado: (2023)

Recent Advances in Treatment of Primary Central Nervous System Lymphoma
por: Nayak, Lakshmi, et al.
Publicado: (2013)

Current State of Immunotherapy for Treatment of Glioblastoma
por: McGranahan, Tresa, et al.
Publicado: (2019)

Clinical Trial Considerations in Neuro-oncology
por: Lee, Eudocia Q.
Publicado: (2021)

Integration of Tumor‐Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies
por: Wang, Yuefeng, et al.
Publicado: (2019)

An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma
por: Swanson, Kenneth D., et al.
Publicado: (2016)

Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
por: Johnson, Adrienne, et al.
Publicado: (2017)

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis
por: Winter, Sebastian F., et al.
Publicado: (2020)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Glioma Immunotherapy: Advances and Challenges for Spinal Cord Gliomas
por: Grady, Clare, et al.
Publicado: (2022)

COVD-17. TUMOR TREATING FIELDS FOR GLIOBLASTOMA THERAPY DURING THE COVID-19 PANDEMIC: EXPERT CONSENSUS ON USE AND EXPERIENCE
por: Tosha Gatson, Na, et al.
Publicado: (2020)

Special Considerations for the Treatment of Pain from Torture and War
por: de C Williams, Amanda C., et al.
Publicado: (2016)

Immunotherapy for malignant glioma
por: Suryadevara, Carter M., et al.
Publicado: (2015)

Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors
por: Overcast, Wynton B., et al.
Publicado: (2021)

Malignant glioma-primitive neuroectodermal tumor recurring as PNET-like only subdural collection: Case report
por: Alvarado, Anthony M., et al.
Publicado: (2017)

Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histology
por: Zaccagna, Fulvio, et al.
Publicado: (2019)

Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement
por: Belhawi, Sinan M. K., et al.
Publicado: (2011)

Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice
por: Thust, S. C., et al.
Publicado: (2018)

Diagnosis and Management of Stroke in Adults with Primary Brain Tumor
por: Komlodi-Pasztor, Edina, et al.
Publicado: (2022)

Intensity standardization of MRI prior to radiomic feature extraction for artificial intelligence research in glioma—a systematic review
por: Fatania, Kavi, et al.
Publicado: (2022)

Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas
por: Schramm, Peter, et al.
Publicado: (2010)

Brain volume perfusion CT performed with 128-detector row CT system in patients with cerebral gliomas: A feasibility study
por: Xyda, Argyro, et al.
Publicado: (2011)

The APOE ε4 allele in relation to pre‐ and postsurgical cognitive functioning of patients with primary brain tumors
por: Butterbrod, Elke, et al.
Publicado: (2021)

Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas
por: Shen, Han, et al.
Publicado: (2020)

Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis
por: Thust, S. C., et al.
Publicado: (2018)

COVD-20. COVID-19 INFECTION DURING CHEMOTHERAPY FOR MALIGNANT GLIOMA: OUTCOMES AMONG 3 PATIENTS
por: Kim, Esther, et al.
Publicado: (2020)

Effect of tumor genetics, pathology, and location on fMRI of language reorganization in brain tumor patients
por: Pasquini, Luca, et al.
Publicado: (2023)

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
por: Cantor, Evan, et al.
Publicado: (2022)

Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus
por: Foss-Skiftesvik, Jon, et al.
Publicado: (2023)

Interstitial chemotherapy for malignant glioma: Future prospects in the era of multimodal therapy
por: Mangraviti, Antonella, et al.
Publicado: (2015)

WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
por: de Billy, Emmanuel, et al.
Publicado: (2021)

Longitudinal visual field archetypal analysis of optic neuritis treated in a clinical setting
por: Branco, Joseph, et al.
Publicado: (2022)

Ependymoma: Evaluation and Management Updates
por: Rudà, Roberta, et al.
Publicado: (2022)

COVD-04. REAL-WORLD PERSPECTIVES: TUMOR TREATING FIELDS (TTFIELDS) UTILITY TO OPTIMIZE TREATMENT OF PATIENTS WITH GLIOBLASTOMA (GBM) AMIDST COVID-19 PANDEMIC
por: Frongillo, Peggy, et al.
Publicado: (2020)

Short diameter may be a useful simple indicator of the tumor response in skull base meningiomas after conventionally fractionated stereotactic radiotherapy
por: Takehana, Keiichi, et al.
Publicado: (2021)

A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes
por: Green, Katherine, et al.
Publicado: (2022)

Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study
por: Acharya, Sahaja, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k63g9c2cscv531llp7dra3f7ua